SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-062684
Filing Date
2023-05-19
Accepted
2023-05-19 16:06:23
Documents
4
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2315164-1_def14a.htm DEF 14A 920238
2 GRAPHIC lg_zurabio-4clr.jpg GRAPHIC 20332
3 GRAPHIC px_zuraextrameet01-bw.jpg GRAPHIC 894934
4 GRAPHIC px_zuraextrameet02-bw.jpg GRAPHIC 1011597
  Complete submission text file 0001104659-23-062684.txt   3341187
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40598 | Film No.: 23940054
SIC: 2836 Biological Products, (No Diagnostic Substances)